Control of argininosuccinate synthetase by arginine in human lymphoblasts.
Human lymphoblasts in long-term culture have the enzyme activities necessary to convert citrulline to arginine: argininosuccinate synthetase and argininosuccinate lyase. Upon transfer from arginine-supplemented to citrulline-supplemented medium, lymphoblasts exhibit a lag period before resuming exponential growth. During this lag the specific activity of argininosuccinate synthetase increases an average of 60-fold. Argininosuccinate lyase activity remains unchanged. If normal lymphoblasts are starved in arginine-deficient medium without citrulline or if argininosuccinate lyase--deficient lymphoblasts are transferred to citrulline-containing medium, argininosuccinate synthetase activity increases linearly for several days and reaches even higher levels. Cycloheximide blocks the increase in enzyme activity. Cells grown in citrulline medium and pulse labeled with 35S-methionine incorporate more 35S-methionine into argininosuccinate synthetase protein than cells grown in arginine; the rate of disappearance of radioactively labeled enzyme is the same in citrulline- and arginine-grown cells. Arginine or a closely related metabolite thus appears to repress the synthesis of argininosuccinate synthetase of human lymphoblasts in culture.
D001120:Arginine / Q000494:pharmacology*; D001123:Argininosuccinate Lyase / Q000096:biosynthesis; D001124:Argininosuccinate Synthase / Q000096:biosynthesis*; D002455:Cell Division; D002478:Cells, Cultured; D002956:Citrulline / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D006801:Humans; D008025:Ligases / Q000096:biosynthesis*; D008214:Lymphocytes / Q000201:enzymology*
D002956:Citrulline; D001120:Arginine; D003513:Cycloheximide; D001123:Argininosuccinate Lyase; D008025:Ligases; D001124:Argininosuccinate Synthase